Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: SGI-110 (guadecitabine)
Total 0 results
Nothing found
Sponsors and Collaborators
Mononuclear Therapeutics Ltd.
North Karelia Hospital District
Maria Lendorf
Yantai Yuhuangding Hospital,Medical College, Qingdao University
Bruce County Paramedic Service
Prestige Biopharma Limited
ImproveCareNow (ICN)
Nestor Soler Porcar, MD, PhD
Bjørgene Omsorgssenter, Haugesund
Veeda Oncology
Reina Sofia University Hospital
Chengdu Nuoen Biotechnologies, Inc.
AIDS Council of New South Wales
Centro di Procreazione Assistita Demetra
Grand Challenges Canada
Neuregenix
Equipe MiMes
BayCare Health System
Women and children's hospital of Jiaxing university
InflaRx GmbH
View Full List
Medical Conditions
Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
Pulmonary Adenocarcinoma
Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
Epidemic Hemorrhagic Fever
Psoriasis, Arthritic
Tay-Sachs Disease Ganglioside
Fetus or Neonate Affected by External Version Before Labor
Gullian Barre Syndrome
Spine Surgeries
Painless Hysteroscopy
Childhood Langerhans Cell Histiocytosis
Endocarditis Infective
Multisystem Proteinopathy
Fracture Dislocation of Cervical Spine
Chlamydophila Infections
Cutaneous Leiomyomata With Uterine Leiomyomata
Predictors of Atrial Fibrillation Recurrences
Skull Base Neoplasms
Closure; Foramen Ovale
Ewing's Family Tumors
View Full List
Drug Interventions
High dose pantoprazole infusion
Chemotherapeutic Agent
Palliative care group first-line scheme
Azelastine hydrochloride (BAYR9258)
Estradiol+Drospirenone
Adriamycin
Redifferentiation with retinoid acid
NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
Mocetinostat - Recommended Phase 2 Dose (70 mg)
Adapalene Gel 0.3%
Qingkailing injection 40 ml
PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
EFV +TVA
Semapimod
Naltrexone 50 mg/day + Cognitive Behavioral Therapy
Esomeprazole 40mg before
Glimepiride
Cereport
Vehicle
Neihulizumab
View Full List
CROs by country
Contract Research Organizations in Armenia
Contract Research Organizations in Bahrain
Contract Research Organizations in China
Contract Research Organizations in Ecuador
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Gabon
Contract Research Organizations in Ireland
Contract Research Organizations in Jamaica
Contract Research Organizations in Jordan
Contract Research Organizations in Luxembourg
Contract Research Organizations in Pakistan
Contract Research Organizations in South Korea
Contract Research Organizations in Switzerland
CRO list by country
CROs in Uzbekistan
SGS
PASPIGIONI
All CROs in Uzbekistan
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe